Results 41 to 50 of about 4,911,045 (202)

The serotonergic system in levodopa-induced dyskinesia

open access: yes, 2014
An increasing body of experimental evidence suggests that serotonergic neurons play a major role in the production of levodopa-derived dopamine when dopaminergic neurons have degenerated, and that unregulated release of dopamine from serotonergic neurons
TRONCI, ELISABETTA   +5 more
core   +1 more source

A Systematic Review of Oral Vertical Dyskinesia (“Rabbit” Syndrome)

open access: yesMedicina
Background and Objectives: Vertical rhythmic dyskinetic movements that are primarily drug-induced and affect solely the jaw, mouth, and lips without involving the tongue have been historically described as “rabbit” syndrome (RS).
Jamir Pitton Rissardo   +6 more
doaj   +1 more source

A case of dyskinesia after levetiracetam administration

open access: yesBMC Neurology, 2019
Background Antiepileptic drug (AED) induced dyskinesia is an unusual manifestation in the medical field. In the previous case reports describing first generation-AED related involuntary movements, the authors suggested that a plausible cause is ...
Soo Hwan Yim   +3 more
doaj   +1 more source

Tardive dyskinesia: apropos of a case. This is a case related to drug side effects, whose uniqueness lies in the time of onset of symptoms, Tardive dyskinesia is a drug-induced hyperkinetic movement disorder.

open access: yesEuropean Psychiatry, 2023
Introduction Tardive dyskinesia is finally diagnosed, it is a drug-induced hyperkinetic movement disorder associated with the use of dopamine receptor blocking agents, including first and second generation antipsychotic drugs, metoclopramide and ...
R. F. Díaz
doaj   +1 more source

Efficacy of subthalamic deep brain stimulation for levodopa-induced dyskinesia in patients with Parkinson's disease: retrospective analysis of 12 cases

open access: yesDi-san junyi daxue xuebao, 2020
Objective To evaluate the clinical effectiveness of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD), and to explore the feasibility and the ...
WANG Kuan   +6 more
doaj   +1 more source

A Case Report of Fosphenytoin Induced Orofacial Dyskinesia in an 11-month-old Baby with Post-encephalitic Sequelae [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Fosphenytoin is used as an alternative phosphate ester prodrug to intravenous phenytoin for seizure treatment. Acute orofacial dyskinesia, secondary to phenytoin treatment is very uncommon. This case report gives the details of an 11-month-old baby girl,
George Mathew Panachiyil   +3 more
doaj   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease

open access: yesNeurology, Neuropsychiatry, Psychosomatics, 2020
Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable complication of levodopa therapy is druginduced dyskinesias, which significantly limits the therapeutic capabilities of this group of drugs and requires treatment adjustment.
A. A. Tappakhov   +4 more
openaire   +3 more sources

Drug-Induced Encephalopathy

open access: yes, 2022
Drug-induced encephalopathy is a condition that is frequently caused by poor cerebral metabolism rather than structural brain abnormalities. On the other hand, several drug-induced encephalopathies may develop structural abnormalities and have common ...
Zehni, Rouzbeh
core  

Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. [PDF]

open access: yes, 2013
BACKGROUND: Drug-related adverse events remain an important cause of morbidity and mortality and impose huge burden on healthcare costs. Routinely collected electronic healthcare data give a good snapshot of how drugs are being used in 'real-world ...
van der Lei Johan   +184 more
core   +2 more sources

Home - About - Disclaimer - Privacy